Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
INO
— Inovio Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
MAR 12, 2026
REVENUE
$0
EPS
$0.05
+106.3%
FREE CASH FLOW
-$19.5M
+9.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →